A recent Reuters article covers the U.S. initial public offering filing of AEVEX, a private equity-backed defense technology contractor. The piece highlights that despite geopolitical volatility, the IPO market remains highly receptive to defense stocks as global military spending accelerates. IPOX® CEO Josef Schuster provided expert commentary on this favorable listing environment, noting: “The IPO window for defense-related firms is wide open... Defense is generational growth.” He also analyzed AEVEX’s strong financial trajectory leading up to its NYSE public debut.

In the U.S., crypto exchange Kraken has frozen its multibillion-dollar IPO amid challenging market conditions, while Samsonite shareholders approved a strategic dual listing. South America sees Brazilian sanitation firm Aegea targeting a massive $7.8 billion valuation. Meanwhile, Asia-Pacific activity remains robust, highlighted by ByteDance-backed Dongchedi's planned $1.5 billion Hong Kong debut and a groundbreaking new partnership between Nasdaq and SGX to establish a unified Global Listing Board.

SpaceX, the rocket manufacturer founded by Elon Musk, is considering a megacap Nasdaq IPO that could value the company at a staggering $1.75 trillion. A listing could occur by June 2026 if the firm secures early inclusion in the Nasdaq 100 index. Meanwhile, Japanese digital payment giant PayPay, backed by SoftBank, successfully debuted on the Nasdaq with a $12.1 billion valuation. IPOX® CEO Josef Schuster noted the company’s unique opportunity to fill a market void despite structural concerns.

In a recent Nikkei feature, IPOX® CEO Josef Schuster provided expert commentary on PayPay's $12.1 billion debut on the U.S. Nasdaq. The Japanese smartphone payment giant, backed by SoftBank, aims to leverage its new capital to build a comprehensive digital financial platform. While acknowledging the fierce competition from established U.S. payment giants, Schuster highlighted a unique opportunity for PayPay to fill a void in the market, despite structural concerns regarding the offering's limited share liquidity.

A recent Reuters article covers the highly anticipated $880 million Nasdaq IPO of SoftBank’s digital payment giant, PayPay. Despite global market volatility, the Japanese app successfully debuted with a $10.7 billion valuation. IPOX® Research Associate Lukas Muehlbauer provided commentary on the offering's strategic pricing and the company's unique market position. Muehlbauer highlighted that we are currently in an IPO "buyers' market" and noted that PayPay's dominant domestic strength insulates it from broader geopolitical and macroeconomic concerns.

The global IPO market is currently heating up with several blockbuster listings in the pipeline. SpaceX is preparing for a record-breaking $50 billion public offering, recently adding Citigroup to its underwriter lineup. In the consumer sector, Roark Capital is weighing a $2 billion IPO for Inspire Brands, the owner of Dunkin'. Meanwhile, Europe anticipates a major boost to the London Stock Exchange as Oaktree Capital Management selects banks for a £2.5 billion listing of wealth management provider Utmost Group Plc.

Reuters covered the Nasdaq debut of Medtronic's diabetes unit, MiniMed, which opened below its offer price amid heightened market volatility. The $5.35 billion listing highlights ongoing challenges in the new issues market. IPOX® Research Associate Lukas Muehlbauer provided expert commentary on the debut, noting that while the offering "shows that the U.S. IPO market is still open," current economic conditions clearly dictate "that it has become a price-sensitive buyers' market."

A recent Bloomberg article highlights the massive outperformance of European defense and aerospace IPOs, which have averaged 87% gains since 2020. Driven by geopolitical tensions and NATO rearmament, this surge in investor demand is prompting a fresh wave of public listings. IPOX® Research Analyst Lukas Muehlbauer provided expert commentary, explaining that ongoing conflicts have created unprecedented backlogs, making IPOs a practical way for defense firms to raise cash and expand capacity.

Reuters highlights SoftBank-backed PayPay’s upcoming $13.4 billion U.S. IPO, a highly anticipated offering expected to boost a volatile listing market. Discussing current market dynamics, IPOX® CEO Josef Schuster noted robust investor appetite is particularly strong for specialty firms across healthcare and select fintech that are insulated from geopolitical and AI-related risks.

Elon Musk’s SpaceX is reportedly preparing to confidentially file for a U.S. initial public offering as early as March, aiming for a record-breaking June listing. This highly anticipated share sale could raise up to $50 billion and command a staggering valuation exceeding $1.75 trillion, bolstered by its recent acquisition of the artificial intelligence startup xAI. SpaceX has already aligned major financial institutions, including Bank of America, Goldman Sachs, JPMorgan, and Morgan Stanley, to lead this historic, market-defining public market debut.

A recent Reuters article highlights Medtronic’s plan to spin off its diabetes unit, MiniMed, targeting a $7.9 billion valuation in its upcoming U.S. IPO. Seeking to raise up to $784 million, the move allows Medtronic to focus on high-margin growth markets. IPOX® Research Associate Lukas Muehlbauer provided expert commentary on the spin-off, noting that while MiniMed offers investors pure-play exposure to diabetes technology as an established business, its recent net losses mean investors will demand a clear path to profitability.

Reuters highlights Generate Biomedicines' upcoming U.S. IPO, targeting a $2.17 billion valuation. As the biotech IPO market resurges, the firm aims to raise $425 million for its AI-driven drug discovery pipeline. IPOX® Research Associate Lukas Muehlbauer provided expert commentary, noting that Generate's institutional backing and pharma partnerships offer significant credibility. However, he emphasized that investors will closely scrutinize the platform's valuation, demanding clear proof of its AI capabilities.

The U.S. IPO market faces headwinds as Clear Street and Liftoff Mobile withdraw their listings. IPOX® Associate Lukas Muehlbauer and IPOX® VP Kat Liu noted that AI-driven volatility and crypto declines forced these moves to avoid "failed" IPO stigmas. Meanwhile, Bain Capital explores a $3 billion IPO for Dessert Holdings. In Europe, Thyssenkrupp plans a $13.5 billion materials spin-off, while UI Boustead REIT preps a $788 million Singapore float.

Reuters reports that Wall Street broker Clear Street has withdrawn its U.S. IPO amid market volatility and AI disruption fears. The withdrawal highlights ongoing challenges for fintech firms navigating weak sector sentiment. IPOX® VP Kat Liu provided expert commentary, noting the risks of forcing a poorly received offering. "If demand wasn't there even at a severe discount, pushing through a weakly received deal would have risked the stigma of a 'failed' IPO," Liu explained

A recent Bloomberg article notes that while recent European stock debuts face market pressure, traditional sectors like banking and energy demonstrate strong resilience. Amid a slow market for follow-on offerings, IPOX® Research Associate Lukas Muehlbauer commented on the challenges of underwater stocks.